Compare ACLS & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACLS | NVST |
|---|---|---|
| Founded | 1995 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.6B |
| IPO Year | 2000 | 2019 |
| Metric | ACLS | NVST |
|---|---|---|
| Price | $144.11 | $27.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $101.50 | $26.46 |
| AVG Volume (30 Days) | 374.2K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | ★ 1.05 | 0.56 |
| Revenue | $839,048,000.00 | ★ $2,566,500,000.00 |
| Revenue This Year | $1.93 | $6.67 |
| Revenue Next Year | $7.91 | $3.55 |
| P/E Ratio | $133.48 | ★ $50.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $73.60 | $18.77 |
| 52 Week High | $193.78 | $30.42 |
| Indicator | ACLS | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 53.58 | 53.93 |
| Support Level | $141.55 | $24.54 |
| Resistance Level | $148.97 | $29.21 |
| Average True Range (ATR) | 7.53 | 0.95 |
| MACD | 2.31 | -0.04 |
| Stochastic Oscillator | 96.61 | 46.51 |
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.